Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Øystein L Holla

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 7, 2005
Identification of deletions and duplications in the low density lipoprotein receptor gene by MLPAØystein L Holla, Christél Teie, Knut Erik Berge, et al.
BMC Cell Biology|March 3, 2007
Degradation of the LDL receptors by PCSK9 is not mediated by a secreted protein acted upon by PCSK9 extracellularlyØystein L Holla, Jamie Cameron, Knut Erik Berge, et al.
Molecular Genetics and Metabolism|October 16, 2009
A chimeric LDL receptor containing the cytoplasmic domain of the transferrin receptor is degraded by PCSK9Øystein L Holla, Thea Bismo Strøm, Jamie Cameron, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 14, 2009
Splice-site mutation c.313+1, G>A in intron 3 of the LDL receptor gene results in transcripts with skipping of exon 3 and inclusion of intron 3Jamie Cameron, Øystein L Holla, Mari Ann Kulseth, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 18, 2009
Loss-of-function mutation R46L in the PCSK9 gene has little impact on the levels of total serum cholesterol in familial hypercholesterolemia heterozygotesThea Bismo Strøm, Øystein L Holla, Jamie Cameron, et al.
Human Molecular Genetics|March 31, 2006
Effect of mutations in the PCSK9 gene on the cell surface LDL receptorsJamie Cameron, Øystein L Holla, Trine Ranheim, et al.
Biochemical and Biophysical Research Communications|May 3, 2011
The cytoplasmic domain is not involved in directing Class 5 mutant LDL receptors to lysosomal degradationThea Bismo Strøm, Kristian Tveten, Øystein L Holla, et al.
Biochemical and Biophysical Research Communications|November 15, 2011
Characterization of residues in the cytoplasmic domain of the LDL receptor required for exit from the endoplasmic reticulumThea Bismo Strøm, Kristian Tveten, Øystein L Holla, et al.
Molecular Genetics and Metabolism|November 15, 2011
Characterization of a naturally occurring degradation product of the LDL receptorKristian Tveten, Thea Bismo Strøm, Jamie Cameron, et al.
Molecular Genetics and Metabolism|July 28, 2010
Disrupted recycling of the low density lipoprotein receptor by PCSK9 is not mediated by residues of the cytoplasmic domainThea Bismo Strøm, Øystein L Holla, Kristian Tveten, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 7, 2005
Identification of deletions and duplications in the low density lipoprotein receptor gene by MLPAØystein L Holla, Christél Teie, Knut Erik Berge, et al.
BMC Cell Biology|March 3, 2007
Degradation of the LDL receptors by PCSK9 is not mediated by a secreted protein acted upon by PCSK9 extracellularlyØystein L Holla, Jamie Cameron, Knut Erik Berge, et al.
Molecular Genetics and Metabolism|October 16, 2009
A chimeric LDL receptor containing the cytoplasmic domain of the transferrin receptor is degraded by PCSK9Øystein L Holla, Thea Bismo Strøm, Jamie Cameron, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 14, 2009
Splice-site mutation c.313+1, G>A in intron 3 of the LDL receptor gene results in transcripts with skipping of exon 3 and inclusion of intron 3Jamie Cameron, Øystein L Holla, Mari Ann Kulseth, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 18, 2009
Loss-of-function mutation R46L in the PCSK9 gene has little impact on the levels of total serum cholesterol in familial hypercholesterolemia heterozygotesThea Bismo Strøm, Øystein L Holla, Jamie Cameron, et al.
Human Molecular Genetics|March 31, 2006
Effect of mutations in the PCSK9 gene on the cell surface LDL receptorsJamie Cameron, Øystein L Holla, Trine Ranheim, et al.
Biochemical and Biophysical Research Communications|May 3, 2011
The cytoplasmic domain is not involved in directing Class 5 mutant LDL receptors to lysosomal degradationThea Bismo Strøm, Kristian Tveten, Øystein L Holla, et al.
Biochemical and Biophysical Research Communications|November 15, 2011
Characterization of residues in the cytoplasmic domain of the LDL receptor required for exit from the endoplasmic reticulumThea Bismo Strøm, Kristian Tveten, Øystein L Holla, et al.
Molecular Genetics and Metabolism|November 15, 2011
Characterization of a naturally occurring degradation product of the LDL receptorKristian Tveten, Thea Bismo Strøm, Jamie Cameron, et al.
Molecular Genetics and Metabolism|July 28, 2010
Disrupted recycling of the low density lipoprotein receptor by PCSK9 is not mediated by residues of the cytoplasmic domainThea Bismo Strøm, Øystein L Holla, Kristian Tveten, et al.
Pageof 4